We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
-14.21%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$89.1B
AUM Growth
+$88.9B
Cap. Flow
-$3.22B
Cap. Flow %
-3.61%
Top 10 Hldgs %
11.59%
Holding
2,672
New
86
Increased
706
Reduced
853
Closed
108

Top Buys

Rank Stock Value
1
HOLX
Hologic
HOLX
+$324M
2
META icon
Meta Platforms (Facebook)
META
+$263M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$175M
4
NEE icon
NextEra Energy
NEE
+$132M
5
SNAP icon
Snap
SNAP
+$116M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$504M
2
AAPL icon
Apple
AAPL
+$433M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$248M
4
VTRS icon
Viatris
VTRS
+$241M
5
AMZN icon
Amazon
AMZN
+$210M

Sector Composition

Rank Sector Weight
1 Technology 21.36%
2 Healthcare 15.43%
3 Financials 13.5%
4 Industrials 10.21%
5 Consumer Discretionary 9.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TGA
2026
DELISTED
Transglobe Energy Corp
TGA
$45K ﹤0.01%
13,339
– –
BOKF icon
2027
BOK Financial
BOKF
$8.64B
$44K ﹤0.01%
581
– –
FATE icon
2028
Fate Therapeutics
FATE
$281M
$44K ﹤0.01%
1,791
– –
FHB icon
2029
First Hawaiian
FHB
$3.42B
$44K ﹤0.01%
1,929
– –
PNTG icon
2030
Pennant Group
PNTG
$1.43B
$44K ﹤0.01%
3,402
– –
KRTX
2031
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$44K ﹤0.01%
351
– –
CIM
2032
Chimera Investment
CIM
$1.05B
$43K ﹤0.01%
1,640
– –
CVCO icon
2033
Cavco Industries
CVCO
$4.39B
$43K ﹤0.01%
220
– –
EGBN icon
2034
Eagle Bancorp
EGBN
$867M
$43K ﹤0.01%
909
– –
RNST icon
2035
Renasant Corp
RNST
$4.01B
$43K ﹤0.01%
1,484
– –
TGTX icon
2036
TG Therapeutics
TGTX
$8.58B
$43K ﹤0.01%
10,190
+5,152
+102% +$32.2K
UPBD icon
2037
Upbound Group
UPBD
$1.19B
$43K ﹤0.01%
2,195
– –
INFN
2038
DELISTED
Infinera Corporation Common Stock
INFN
$43K ﹤0.01%
7,932
– –
DNLI icon
2039
Denali Therapeutics
DNLI
$3.67B
$42K ﹤0.01%
1,411
– –
KNSA icon
2040
Kiniksa Pharmaceuticals
KNSA
$4.83B
$42K ﹤0.01%
4,353
– –
PRTA icon
2041
Prothena Corp
PRTA
$458M
$42K ﹤0.01%
1,548
– –
WOW
2042
DELISTED
WideOpenWest
WOW
$42K ﹤0.01%
2,293
– –
CMRC
2043
Commerce.com Inc Series 1
CMRC
$224M
$41K ﹤0.01%
2,505
– –
GIC icon
2044
Global Industrial
GIC
$1.34B
$41K ﹤0.01%
1,208
– –
HCC icon
2045
Warrior Met Coal
HCC
$4.23B
$41K ﹤0.01%
1,338
– –
KRYS icon
2046
Krystal Biotech
KRYS
$9.88B
$41K ﹤0.01%
628
– –
LCID icon
2047
Lucid Motors
LCID
$2.46B
$41K ﹤0.01%
238
– –
MGNI icon
2048
Magnite
MGNI
$2.65B
$41K ﹤0.01%
4,638
– –
FLNA
2049
Filana Therapeutics
FLNA
$43M
$41K ﹤0.01%
1,454
– –
AERI
2050
DELISTED
Aerie Pharmaceuticals
AERI
$41K ﹤0.01%
5,498
– –
80 81
82
83 84

Similar funds

AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
BCIM
British Columbia Investment Management Victoria, British Columbia, Canada $17B AUM 31.69% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return

Macquarie Group's Q2 2022 Portfolio in Review

As of Q2 2022, Macquarie Group held 2,672 positions worth $89.1B, up 67,641% from $131M the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Macquarie Group withdrew a net $3.22B in Q2 2022, closing 108 positions and reducing 853 holdings. Its most notable exit was Healthcare Realty, an estimated $10.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Macquarie Group opened a new position in Petco worth $56.3M.

  • Macquarie Group's largest Q2 2022 buy was Petco: 3,818,489 shares worth $56.3M.
  • Macquarie Group added most to Hologic in Q2 2022, an estimated $324M increase.
  • Macquarie Group's biggest Q2 2022 reduction was Microsoft, cutting an estimated $504M.
  • Macquarie Group fully exited Healthcare Realty in Q2 2022, selling an estimated $10.8M.
  • Macquarie Group's ten largest holdings make up 12% of its $89.1B portfolio in Q2 2022.
  • Macquarie Group opened 86 new positions and closed 108 in Q2 2022.
  • Macquarie Group's portfolio value rose 67,641% quarter-over-quarter to $89.1B.

Based on Macquarie Group's 13F filing for Q2 2022, filed 15 Aug 2022.